>teicoplanin_2_1
LAGTGLRRRDIAQWLVHSGGKKVIDAVVVNLGLTRHDVRHTTRILRDYGNVSSGSFLFSYERLVEEGVTRPGDYGVLMTMGPGSTIETALVQW
>vancomycin_1
GTGLRRSDIGHWLVHSGGKKVIDAVVVNLGLSRYDVRHTTGVLRDYGNLSSGSFLFSYERLADEDVARPGDYGVLMTMGPGSTIEMALIQW
>mupirocin_1
HRQQINTADLEQVVCSNVFLPVLKIKEGRQGVSGTQLYVDNVTRVGHCFSADSLINLCDYQARAQQVHGGLVMLTANADGLRCQTLL
>daunorubicin_1
LKAAGVGLDDISRVVLPHMGWRRLSASYFGKWPVPPERTTWEFGRRTGHLGGGDPIAGFDHLVGSGRLAPGELCLLVSVGAGFSWSCAVVE
>ristomycin_1
GTGLRRSDIGHWLVHSGGKKVIDAVVVNLGLSRHDVRHTTGVLRDYGNLSSGSFLFSYERLADEDVARPGDYGVLMTMGPGSTIEMALIQW
>dutomycin_1
LEEAGIGRSDITRVAYVNYARLATQMWLLDPLGIPMSTSTWEIGRHIGHIGPSDQLVSLDRLLSRGELGPGDHVLLAGLGPGMTLGSAVLEI
>R1128_1
LEVAGLTVGDLVAFVPHQANLRIIDVLVDRLGVPEHVVVSRDAEDTGNTSSASVALALDRLVRSGAVPGGGPALMIGFGAGLSYAGQAL
>lipopeptide_8D11_1
AHAGWDLADVDAFVGHQANLRILTSVAKRLGLPRERVVSNIADVANTAAASIPLALADAAAEGRIGSGDRLLLTAFGGGLTWGSAAVVW
>A_74528_1
LDLAGVTTDRLDAFIPHQANMLITDVVVEQLGLTERTSVARDIVTSGNSSAASIPLAMEELLSSGHAPSGGLALLVGFGAGLVYAGQVVR
>thiomarinol_1
RNQITISDLSKVFSNNLYMPVITLKEGGIGVSKSQLYLDNIVRFGHCFSADSIINLADYLANSRVAAGEYFALHSSASGLRAQ
>quinocarcin_1
RIGADVSDLSRVVFLNDNARTLKDVSGKIGVPLDRTNFDISLEHGHFGAADHLFNLRRHILDDAVKPGDLIALAGMGRGMHWACALIE
>A40926_1
GTGLRRSDIGHWLVHSGGKKVIDAIVVNLGLSRHDVRHTTAVLRDYGNLSSGSFLFSYERLAGEGVTRPGDYGVLMTMGPGSTIETALIQW
>xenocyloins_1
LSRHNLVPADIKGFMFSQFSVSNIRRLCEELGVDQDKALFIGDEYGYTATNSPFVALYETLERKKIVRGDFLIFWTIGAGWQSIAVLMQ
>xenocyloins_2
CQSNGMSLNEVSAFYVYDPSDWVASAAAEALGVGKDKIISIFHKYGSLGPAQSFFGFMEMQDNKNLTDSDWVIVMGLGPSTTATAVLFRW
>abyssomicin_1
ELGWARDDLDYVLPPQLSGRMTALIVERLKLPQATEVSCVAETGNNGNGIVFLQLERALARLAGGQRALGVS
>eponemycin_1
ESAGWSLEDVDRFAAHQANARILEAVADELAIPAGHRLSNISRVGNTGAASIPLLLAQAAEDSSLAEGHRTLLTAFGGGLAWGAATLTW
>A33853_1
AEAGVALSDIRRFCHVGFNEDPLLTMFLEPLGVSLEQGTWDICRRIGHTGVSDFVISLERLWLDGEVGPGDHVMLIGAATGMEAGCAVLEI
>teicoplanin_1
LAGTGLRRRDIAQWLVHSGGKKVIDAVVVNLGLTRHDVRHTTRILRDYGNVSSGSFLFSYERLVEEGVTRPGDYGVLMTMGPGSTIETALVQW
>maklamicin_1
LDEAGIGIADVTRVAPMNFSRALIERLMGGLGLTMAHSTWAWGSTVGHLGASDQVVALDHLLATGDLGPGDHLLMLGIGPGVTLSCAVVG
>maklamicin_2
LDELDWQDDEVDYLLPPQLSGRMTARITAALGLPGAYEVSCVADIGNTGNALPFFQLEQVMPKMAAGDRAVGVA
>maklamicin_3
LAEAGIDISDVTRVAYMNYSREIVEQRCTAALGLPLSASTWDWGRGLGHLGASDQVAALDHLIGTGQLGPGDHLLMLGVGPGVTVSCAVVQI
>corallopyronin_1
DITIKDCRYVIPHQPSRVVLDYLSLTYPDDKLVRIIDRFANCIGASMPMALYEAVKVGGLRRGERGVLTGTGSGVSFVGMVFT
>2_4_diacetylphloroglucinol_1
AKIHAQADDFDYVVFQQNLVSTPYSLGKHLGFTKAQIEPGIYAQSVGDAGAASPLLGLVNVLDQARPGERILVVSYGFGAGSD
>2_4_diacetylphloroglucinol_2
DFFIFHTGGREILDELVLQLDLEPGRVAQSRDSLSEAGNIASVVVFDVLKRQFDSGPVNGATGMLAAFGPGFTAEMAVGKW
>PQS_1
LEKAGLGSDDIDYFVFHQPAPFLVKAWAEGIGARPEQYQLTMGDTGVMISVSIPYTLMTGLREGKIRPGDRIVMAGAATGWGFAAQVWQ
>PQS_2
LAAHELTLDDIDHVICHQPNLRILDAVQEQLGIPQHKFAVTVDRLGNMASASTPVTLAMFWPDIQPGQRVLVLTYGSGATWGAALYR
>esmeraldin_1
LAEVGLTMDQVARVTHVGFHHGSLHALYLEPLGIDADRGTWEHSRRIGHASMSDVVIGLEHLWLTRQVNPGDRVLMIGTTPGMEVGCAVVEI
>aclacinomycin_2_1
LAAAGAGLADIDRFVLPHMGRKRLRAGFLNRLGIGEDRTTWEWSRGVGHLGAGDQIAGFDHLVGSGSLGPGDLVLWMSVGAGFTYSCAVVEM
>argimycin_1
LESAGVDSGDIEAFVPHQANGRIIDAVVKNMKLPASVAVARTIREDGNTSAASVPLAMDHLVSTGQVRRGGLALTVGFGSGLGYSAQVIT
>rishirilide_b_1
LAEADCTLADLSWFVLPNFGRGRLNSTFLRRWSIEEERTTWRWGRSVGHLGAGDQFAGLAFLAESGRARAGELGLLFGVGAGFTWSCAIVE
>red_pigment_1
DHRWDVAGLDFYVIHAGGPRILDDLTKFLGVPSEAFRHSRATLAQYGNIASAVVLDALRRIIEEGRLESGARGMIAGFGPGITAEMSV
>phenalinolactone_1
LEEAGVTADDITHVLIHGMPRRAAASYLRILGFPLERSTWDFSRTVGHLGASDHMAALHHLLATERLHAGDHVLLCGFSPGVTYKAAVVR
>frenolicin_1
LRESGIEPEALDAFVPHQANLRMIELMAERLGLPERTAVARDVVRAGNTSAASVPLALEALLDSGEVGSGDRALLVGFGAGLNYAAQVVE
>pactamycin_2_1
EAGITVPDLSHVLHLGAATTDFLDSHLRPMGLDASLGSVEFFRDVGHHAGAADVGIHLDHLACSGRLAAGDHLLMLSAGPGLMITAAVVT
>cinerubin_1
LASAGVALGDVDRFVLPHLGRKRLRAGFLARFGIAEERTTWEWSRTVGHLGAGDQFAGFDHLVSSGTLAAGDLVVWMSVGAGFTYSCAVVEI
>herboxidiene_1
GWDISDLDFYIVHAGGPRILDDLSKYLMLPSETFRYSRATLTERGNIASAVIFDALDRLFEEGGAAEGARGLIAGFGPGITAEISLGRW
>tetronasin_1
LDDVGWKDSDVDAVLPPQHSGRVTERVCELLGVAESSVTSRVEETGNNGNGLLLFQLERALAGLGSGGRVV
>tetronasin_2
LHELSWDAEQVRYILPPQLSARMTDRTLSHLALPGSEPISRVTEIGNTGNAIPYFQLELLLPRLNPGDRAVGIS
>coumermycin_1
LHEAGVDARDIKTVLIHSMPRQAAASYLKILGFSLDRSTWEFSRTTGHLGAGDHLAALYHLLSTGEVGPGDNLLLCGSSPGVTYKAAVIRI
>sanglifehrin_a_1
DGAGVDPGQVKRFLFLNDNQDSLADVAKAVGVPLDRTNAELAKDLGHCGGADQLICLDTLLERGELAEGDVVALAGLSIGMHWYCTLLT
>oxazolomycin_1
LADAGIGKDDVAATLMQNVTSSAFDFYKATLGLPIHPVCATHLAELGHLGPMDVVLNLDRLLATGEVGPGGHVLVLSNSPVAAWTVTLW
>SF2575_1
SAGVSADDVDRFIVHQGNARLVESVADLLGVEMARVPLSAPLYGNTGAAALPLTLHHSHRERPLERGERILFAAVGGGMTAGAALLTW
>SF2575_2
GGIKLADVDKLVYHNMAGFIVGFFAEQMGLSLEHSTWEFGRTLGHLGCSDQAVGLEHLLLTGELSPGDRVMLLAASAGFATSCILLEI
>polyketomycin_1
AATGLGVEDVTFLSYMNTSRTTIEKRLLPLLGLPAERTTWEVGRDIGHLGVSDQLVALDRLLCDGRLKPGDHYLMYGLGPGMTVAGAMFEI
>aresnopolyketides_1
LAEAGLEPGDVTRVCHVFTGQESYLKVILDPMGLSPDQGLLDFGRNLGHMTVNDQIVGLTHLVETGQVGPGDHVLIVAHGGGVSITCAVVRI
>avilamycin_1
LAGAGIGMADVARVSFMNYHAKWSSSAEWRPGGCRCPGPRGNSAGRSATCGASDHLLSMEHIVRTGELAPGDHVLQLATAPGLVVSSAVLQ
>undecylprodigiosin_1
LDRAGWRVADVDWLVSHQANHRITARLADEIGIPRERSVSNIAEVGNTAAASIPLALDHAHARGTLRPGDRVLLTAFGGGLTWGAAALTW
>divergolide_1
LAGAGVRAEEIDCFVPHQANAVLIRELAARCGLADTPLVQVVETYGNTGAASVPIGLDHAVREGTVEPGGLVLLSAFGAGMSVGNGLLRW
>U_68204_2_1
LQDLSVPPDQVRHFIPHQANGAMLGEVLENLGLPRARAHLPVGRHGNTGAASVPLALDHAHRSGELSDGDLVLLAGFGGGMTMSAALLAW
>flaviolin_1
DHRWDVAGLDFYVIHAGGPRILDDLTKFLGVPSEAFRHSRATLAQYGNIASAVVLDALRRIIEEGRLESGARGMIAGFGPGITAEMSV
>alnumycin_1
REAGLTPAELGAFVPHQANLRMIELMTERLGLTGATAVSRDVVRSGNTSAASIPLALEALLASQEASTGDTALLVGFGAGLNFASQVV
>viguiepinol_1
LHKCGVVPDDIDHFVPHQANGTMLDSLFADLELPRATMHRTLTHYANTGAASIPITLDAAARAGAFNPGDLILMAGFGGGMSAGFALVEW
>nataxazole_1
LKQADVSWDQIAKVCHVGFGRPALEAMFLLPLDVPEEKTVWEYANTIGHTGAADLFLGLEHVWRTGQVGPGDHVLLIGASTGMEAGAAVVRI
>lasalocid_1
DIAPDAVDHFVPHQANGMMLREVLPLLGLPRARTHLTVAEHANTGAASVPLALDTVRRGGLLEDGDTVLLAGFGGGMSLGTALVRW
>simocyclinone_4_1
DRAGCTLDDIQVVIAPNPNTTLWQDTIKDEALRSKFFFDNIPRYSHCLASDVLINYATLGEEKRFEPDRPAMFVAIGVGMTFSAMVF
>calicheamicin_1
LAEAGIGTGDLAKVSFMNYSREVVEQRCMAPLGLGMEKSTWDFGRMIGHCGASDHLLALHHSLRAGEVAAGDHVLWLAMGPGVEFTAAVLR
>balhimycin_1
GTGLRRSDIGHWLVHSGGKKVIDSVVVNLGLSRHDVRHTTGVLRDYGNLSSGSFLFSYERLAEEGVTRPGDYGVLMTMGPGSTIEMALIQW
>marineosin_1
LDRTGWRVEDVDHLVAHQANHRITRRLADEIGLPRERAVSNIAEVGNTAAASIPLALAHAHAAGALTPGDRVLLTAFGGGLTWGATTLTW
>tiacumicin_1
AECGLALSDLDRVAFMNYSREVVEQRCMAPLGLPMARSSWDYGRTIGHCGASDHVLSLKHFVDTGQLRPGQHMLLLGTGPGINLACAVIKI
>prodigiosin_1
LDRAGWPAGDVSHLVTHQANHRIVERLADELGIPRERGICNISEVGNTATASLPLTLGHAHAARLPKPGDRVLLTAFGGGLTWGATVLTW
>calcium_dependent_antibiotic_1
AHAGWDLADVDAFVGHQANLRILTSVAKRLRLPPERVVSNIADVANTAAASIPLALADAAAQGRIGSGDRLLLTAFGGGLTWGSAAVVW
>napyradiomycin_1
HSWDAGKLDFYIVHAGGPRILDDLARFLDVDRQVFRHSWSTLTEYGNIASAVVFDAARRLFEEGSAKPDATGMIAGFGPGITAEMALG
>simocyclinone_1
DRAGCTLDDIQVVLAPNPNTTLWVDTIKDDALRSKFFFDNIPRYSHCLASDVLINYATLCEEKRFEPGRPAMFVAIGVGMTFSAMVF
>benastatin_1
IERAGVTSEELSAFIPHQANGLITDALAKDIGLTADTAIARDITDSGNTSGASIPMAMERLLASGQARSGEAALLIGFGSGLVHAGQVV
>feglymycin_1
QGTALRRSDIKHWLVHSGGKKVIDAVIVNLGLTRYDLRHTVGVLRDHGNVSSGSFLFSYERLLDEKVTQPGDYGVLMTMGPGSTIETALVQW
>aclacinomycin_1
LAAAGAELADIDRFVLPHMGRKRLRAGFLNRLGIGEDRTTWEWSRGVGHLGAGDQIAGFDHLVGSGSLGPGDLVLWMSVGAGFTYSCAVVEM
>reveromycin_1
LAAAGTDPAELGAFIPHQANLRIVDAAVAALGLPPHVAVSRDVTDTGNTSAASIPLAMERMVAQGRAGSGDLALLVGFGAGLTHAAMVVA
>cystargolide_1
AVGWRTEQIDAFVGHQANARILRAVGRRLGLAEERVVCRLAEVGNTAGASIPLALAQAAADDRLSKGDRVLMTAFGGGLTWGSAAMVW
>alkyl_o_dihydrogeranyl_methoxyhydroquinones_1
LAKRGLRIADIDGWAVHPGGPKILDVVQERLELDDAALAPSRGVLEAYGNCSSATVLLVLDALRRQEDPPRRIVMLAFGPGLTLYVTLL
>thiotetroamide_1
LSVPPEEIRHFIPHQANGAMLRDIWGHLGLPHAHLHMPVARHGNTGAASIPIALDHAHRSGRLAAGELVLLAGFGGGMTMGTSLISW
>merochlorin_1
LHEAGVTPDDIRHFVPHQANGRLLETVFTDLALPNATMHQTLTHYANTGAASLPITLDAAARQGAFHPGDLVLLAAFGGGMAAGLALIEW
>merochlorin_2
HSWDVGNLDFYIIHAGGPRILDDLAKFLDVDRQVFRHSWATLTEYGNIASAVVLEAARRLFEEDTPKPDATGLIAGFGPGITAEMALGRW
>doxorubicin_1
LEAAGAGLDDISRVVLPHMGWRRLSAAYFNKWHIQPERTTWEFGRRTGHLGGGDPIAGFDHLVGSGRLAPGELCLLVSVGAGFSWSCAVVE
>lobophorin_1
LDALNWDRGEVDYVLPPQLSGRMTDEIHARLDVPDAQEVSCVRETGNTGNALPFFQLERLLPRMIAGDRAVGVA
>carbamidocyclophane_1
LADNNIESENIYRWIVHPGGPKVIDTVEAEFGLDSRTLQLSRDTLAEVGNISSATVLYMLDKVLSGEQSPPDSYGLVVAMGPGFAQEAILLKW
>naringenin_1
EQHQWNAGKLDFYIIHAGGPRILDDLSRFLDVPPGAFRHSRATLTEYGNIASAVVLDALGRLFDEQSALDGHHGMLAGFGPGIIAE
>tetronomycin_1
DWKADELAYVLPPQLSGRMTALIRERMGAPEAQEVSCVDETGNNGNALVFFQLARLLPKLTAGDRALGVA
>salinamide_1
CERAGTTVGDLDWLVMHQANRRILDAVAKDLGIDQDRVARDIIDAGNTSAASVPLALLALRESGATRPGESALFLGFGAGLTYAGQVVT
>napyradiomycin_2_1
HSWDAGKLDFYIVHAGGPRILDDLARFLDVDRQVFRHSWSTLTEYGNIASAVVFDAARRLFEEGSAKPDATGMIAGFGPGITAEMALG
>endophenazine_1
LHEAGVVPDDIGHFVPHQANGVLLDAVTADLGLPRAASHRTLAHYGNTGAASIPITLDTAARAGAFRPGDLILLAGFGGGMSAGLALVEW
>cosmomycin_d_1
LADAGLGLADIDRFVLPHLGHRRLHVAYFAKFGIDPARSTWSWSRTIGHLGAGDPFAGLDHLATAGELGPGDTCLLFGVGAGFSWSCAVVEI
>pheganomycin_1
LRHSGVPPSRVGHWIVHSGGKKVIDAVRVNLGLTRHDVRHTTGVLRDHGNLSSGSFLFSYQRLAAEDRTRPGDHGVLMTMGPGSTIEMALARW
>phenolic_lipids_1
FAIHPGGPKIVDHVQEELGLAEDQVAISKSVFLENGNMSSSTIPHILKAYLEEATVGTRIACLGFGPGLTAAGLVLE
>phenolic_lipids_2
FAIHPGGPKIVEHIQEDLGLSDEQVAISKSVFLENGNMSSATIPHILKQVLEEVDVGTRVLCLGFGPGLTVTGMVLE
>flexirubin_2_1
MDKNNIKSEDINYFIPHVSSNFFVEGLKKGLSEKGIGMSDEKWFMNLSRVGNVGSASIYLALEELMNSGNLKKGDHILLS
>lobosamide_1
LAVAGVTLDDIRLVLPHNVNVVTWHRLCRLIGLPRDRVLLDNVRDTGHVFCADAFANYLTARERGLLDPGDRYLVAAVGAGDGATFAAMV
>versipelostatin_1
TSHDVAADGVDHFVPHQANGVLLNRLFPLLGLARARMHLTVAEHGNTSAASIPLALDHGNRTEAFHDGDLLLLAGFGGGMSIGTALVRW
>versipelostatin_2
LDTLGWDETDVDYLLPPQLSGRMTRRITETLAVPGAHEVTLVDEIGNTGNAVAFFQLEHLLPRMSDGDRAI
>RK_682_1
GWTADQVDYLLPPQLSGRMSDRISDAMPAPLAQRVNVVRTVGNNGNALPFLQLAELLGQWQGGGRAVTVA
>pamamycin_1
IERSGWTVEDVDRLATHQANARISEAVADELGVPRDRVLSNIEHVGNTSAASLPLLLADSAAAGRLRTNDRVLLAAFGGGLAWGAASLTW
>pamamycin_2
LRRNDMTIADVDRVVPHPGSARISEELVRRIGVAPERVLTNLRTRGQTTSATIPSALSEFTESGELRKGNVILSPAAGAGWFSGALLYQ
>pamamycin_3
LKRNGLAPEQISWCIPHQANTNLLYPMADRLGIPRERMLLNLPRRGNTSSVGMPSALSEYVGDGTVKPGELLLGVSIGRGLSWGAMVFRY
>pamamycin_4
GRNKLAIGDIDWLIPHSGTEPLAKGIQHNLGADPARVLTNLAFRGNVSSASIPTTVSELRERGVVKPGDLVLSPSIGGGVWCWGSLLYRI
>clorobiocin_1
LHEAGVDARDIKTVVIHSMPRQAAASYLKILGFSLESSTWEFSRTTGHLGAGDHLAALHHLLSTGKVGPGDNLLLCGSSPGVTYKAAVIRI
>kendomycin_1
AGTSLRRSDIEHWVVHSGGKKVIDSVMVNLGLTRHDVRHTTGVLRDYGNLSSGSFLFSYERLLDSGVVRRGDYGVFMTMGPGSTIETALLRY
>galbonolides_1
LDETGVRPEGIARVVPIAIGAEVLDLLLGGAPLGLRAADTSWTFGRHLGHVGPCDVLLALDREFRSGTLRAGERVLVVSFGLGFRWTTALLEI
>cosmomycin_1
LADAGLGLADIDRFVLPHLGHRRLHVAYFAKFGIDPARSTWSWSRTIGHLGAGDPFAGLDHLATAGELGPGDTCLLFGVGAGFSWSCAVVEI
>U_68204_1
LSVPPEEIRHFIPHQANGAMLRDIWGHMGLPRAHLHMPVARHGNTGAASIPIALDHAHRSDRLAAGDLVLLAGFGGGMTMATSLISW
>furaquinocin_a_1
HSWDVGKLDFYIVHAGGPRILDDLARFLEVDREVFRHSWSTLHEFGNIASAVVLEAARGLFEEDALAPGATGLSAGVGPGITAE
>furaquinocin_a_2
LHDSGVGPDDIRHFVPHQANGVMLDALFAELALNRAVMHRTLTHYGNTGAASIPITLAEAARSGAFRPGDLILLAGFGGGMAVGFALVEW
>pactamycin_1
EAGITVPDLSHVLHLGAATTDFLDSHLRPMGLDASLGSVEFFRDVGHAGAADVGIHLDHLACSGRLAAGDHLLMLSAGPGLMITAAVVT
>cervnimycin_1
LEDAGTAIEDIAHAVIPVSRRGTGHELHDLLGLPDERTSWAYGRTTGHVGAGDQYAGLAHLVENALVQPGDRVLLFGGGAGYTCTAAVVEI
>pseudopyronine_1
QNLTADDVHKVFIHTGSPKMWEHIGQMIGVDHKLHHVGHKTGNIITASIPFGIFDAMSRGEAEPGQFCMGWAGSGGMVFSALS
>eicosapentaenoic_acid_4_1
LAQRDWVVENVDKVICHQVGASNRRQVLNALNIPVNKEFPTYKLMGNMGSVSLPATAAMAHDHGFLKSGDNVSFLGIGSGLNCMMLGLKW
>kijanimicin_1
LDALDWDRGELDYVLPPQLSGRMTDAILARLDVPDAREVSCVRETGNTGNALPFFQLERLLPHMITGDR
